Combination therapy of imipramine with oxybutynin in children with enuresis nocturna.
OBJECTIVE
The treatment approach for enuresis is controversial due to the lack of consensus as to the exact causes of nocturnal enuresis. Despite various treatment modalities, pharmacotherapy still appears to be the common choice. The aim of this prospective study was the evaluation of the efficacy of combination therapy (imipramine and oxybutynin) in patients with enuresis nocturna.


METHODS
This prospective study was done with 77 monosymptomatic nocturnal enuretics between July 1996 and December 1998.


RESULTS
Even though there is no statistically significant difference between combination therapy (imipramine plus oxybutynin) and monotherapy, clinical data showed that combination therapy is more effective.


CONCLUSIONS
We conclude that combination of imipramine with oxybutynin is a safe and new choice in the treatment of nocturnal enuresis.
Tahmaz
L
L
Department of Urology, Gülhane Military Medical Academy, Ankara, Turkey.
Kibar
Y
Y
Yildirim
I
I
Ceylan
S
S
Dayanç
M
M
D000293:Adolescent; D000929:Antidepressive Agents, Tricyclic / Q000627:therapeutic use*; D002648:Child; D018680:Cholinergic Antagonists / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004775:Enuresis / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007099:Imipramine / Q000627:therapeutic use*; D008297:Male; D008333:Mandelic Acids / Q000627:therapeutic use*; D011446:Prospective Studies; D016037:Single-Blind Method; D013997:Time Factors
D000929:Antidepressive Agents, Tricyclic; D018680:Cholinergic Antagonists; D008333:Mandelic Acids; C005419:oxybutynin; D007099:Imipramine